安图生物
(603658)
| 流通市值：194.74亿 | | | 总市值：194.74亿 |
| 流通股本：5.71亿 | | | 总股本：5.71亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,057,927,123.1 | 992,202,191.51 | 4,226,413,277.24 | 3,127,156,171.6 |
| 营业总成本 | 1,551,661,922.35 | 758,254,185.72 | 3,171,017,904.49 | 2,294,860,260.37 |
| 其他经营收益 | | | | |
| 营业利润 | 549,675,743.28 | 262,754,207.9 | 1,217,929,013.35 | 952,196,649.69 |
| 利润总额 | 546,153,384.66 | 261,986,759.65 | 1,222,766,392.56 | 959,174,314 |
| 净利润 | 502,204,100.87 | 239,137,278.56 | 1,086,384,222.05 | 872,725,088.32 |
| 每股收益 | | | | |
| 其他综合收益 | -331,982.96 | -160,461.9 | -195,065.28 | -84,048.63 |
| 综合收益总额 | 501,872,117.91 | 238,976,816.66 | 1,086,189,156.77 | 872,641,039.69 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,512,857,627.56 | 6,093,324,729.44 | 6,308,275,297.16 | 5,880,262,392.78 |
| 非流动资产: | | | | |
| 非流动资产合计 | 6,271,244,752.27 | 6,148,893,448.97 | 5,981,449,834.54 | 5,846,682,436.92 |
| 资产总计 | 11,784,102,379.83 | 12,242,218,178.41 | 12,289,725,131.7 | 11,726,944,829.7 |
| 流动负债: | | | | |
| 流动负债合计 | 2,273,381,624.36 | 2,278,136,483.34 | 2,629,301,146.1 | 2,280,644,264.58 |
| 非流动负债: | | | | |
| 非流动负债合计 | 743,177,608.05 | 708,863,302.82 | 644,182,410.01 | 600,755,206.63 |
| 负债合计 | 3,016,559,232.41 | 2,986,999,786.16 | 3,273,483,556.11 | 2,881,399,471.21 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,674,379,764.28 | 9,162,441,066.51 | 8,926,154,166.03 | 8,746,504,579.1 |
| 股东权益合计 | 8,767,543,147.42 | 9,255,218,392.25 | 9,016,241,575.59 | 8,845,545,358.49 |
| 负债和股东权益合计 | 11,784,102,379.83 | 12,242,218,178.41 | 12,289,725,131.7 | 11,726,944,829.7 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,422,587,625.22 | 1,230,595,128.87 | 4,919,236,784.49 | 3,581,762,531.26 |
| 经营活动现金流出小计 | 2,206,745,664.19 | 1,084,022,628.37 | 3,577,555,021.74 | 2,736,340,717.87 |
| 经营活动产生的现金流量净额 | 215,841,961.03 | 146,572,500.5 | 1,341,681,762.75 | 845,421,813.39 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,035,997,435.48 | 2,227,823,742.53 | 4,980,273,193.85 | 4,040,066,091.92 |
| 投资活动现金流出小计 | 4,776,546,707.51 | 2,058,586,141.46 | 5,395,623,707.12 | 3,801,634,004.4 |
| 投资活动产生的现金流量净额 | 1,259,450,727.97 | 169,237,601.07 | -415,350,513.27 | 238,432,087.52 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 848,052,046.61 | 163,850,000 | 2,018,634,905.01 | 1,582,459,788.59 |
| 筹资活动现金流出小计 | 1,647,258,204.43 | 265,857,476.05 | 2,814,927,795.44 | 2,529,002,548.46 |
| 筹资活动产生的现金流量净额 | -799,206,157.82 | -102,007,476.05 | -796,292,890.43 | -946,542,759.87 |
| 汇率变动对现金及现金等价物的影响 | -17,706,566.05 | -7,662,969.99 | 774,015.75 | 2,418,501.37 |
| 现金及现金等价物净增加额 | 658,379,965.13 | 206,139,655.53 | 130,812,374.8 | 139,729,642.41 |
| 期末现金及现金等价物余额 | 1,241,250,688.74 | 789,010,379.14 | 582,870,723.61 | 591,787,991.22 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 658,379,965.13 | - | 130,812,374.8 | - |
最新报告期：2026-09-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 喻胜锋,李虹达,王在存,贺菊颖 | 1.82 | 1.98 | 2.13 | 2026-09-30 |
| 华创证券 | 郑辰,张良龙,李婵娟 | 1.90 | 2.18 | 2.44 | 2026-09-17 |
| 申万宏源 | 凌静怡 | 1.89 | 2.08 | 2.33 | 2026-09-08 |
| 中金公司 | 俞波,张琎,陈诗雨 | 1.94 | 2.16 | -- | 2026-08-26 |
| 华泰证券 | 代雯,孔垂岩,王殷杰 | 1.81 | 2.02 | 2.29 | 2026-08-25 |